title: Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels.
abstract: Hydrogen sulphide (H2S) has been recently hypothesized to be an endogenous adipocyte-derived relaxing factor, evoking vasorelaxation of conductance and resistance vessels. Although the activation of ATP-sensitive potassium channels is known to play a central role in H2S-induced vasorelaxation, activation of vascular Kv7 voltage-gated potassium channels has also been suggested. To investigate this possibility, the ability of selective activators and blockers of distinct classes of potassium channels to affect vasodilation induced by the H2S-donor NaHS, as well as NaHS-induced Rb(+) efflux in endothelium-denuded rat aortic rings, was investigated. NaHS-induced changes of membrane potential were fluorimetrically assessed on human vascular smooth muscle (VSM) cells. Modulation of Kv7.4 channels by NaHS was assessed by electrophysiological studies, upon their heterologous expression in CHO cells. In isolated aortic rings, NaHS evoked vasorelaxing responses associated with an increase of Rb(+)-efflux. NaHS promoted membrane hyperpolarization of human VSM cells. These effects were antagonized by selective blockers of Kv7 channels. The H2S-donor caused a left-shift of current activation threshold of Kv7.4 channels expressed in CHO cells. Altogether, these results suggest that the activation of Kv7.4 channels is a key mechanism in the vascular effects of H2S. Given the relevant roles played by Kv7.4 channels in VSM contractility and by H2S in circulatory homeostasis regulation, these findings provide interesting insights to improve our understanding of H2S pathophysiology and to focus on Kv7.4 channels as novel targets for therapeutic approaches via the "H2S-system".
authors.affiliation: Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy. martelli@farm.unipi.it
authors.forename: A
authors.initials: A
authors.lastname: Martelli
authors.forename: L
authors.initials: L
authors.lastname: Testai
authors.forename: M C
authors.initials: MC
authors.lastname: Breschi
authors.forename: K
authors.initials: K
authors.lastname: Lawson
authors.forename: N G
authors.initials: NG
authors.lastname: McKay
authors.forename: F
authors.initials: F
authors.lastname: Miceli
authors.forename: M
authors.initials: M
authors.lastname: Taglialatela
authors.forename: V
authors.initials: V
authors.lastname: Calderone
mesh_terms: D000818:Animals; D001011:Aorta / Q000187:drug effects* / Q000378:metabolism; D002460:Cell Line; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D006862:Hydrogen Sulfide / Q000494:pharmacology*; D066298:In Vitro Techniques; D051656:KCNQ Potassium Channels / Q000096:biosynthesis / Q000378:metabolism*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013440:Sulfides / Q000494:pharmacology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D051656:KCNQ Potassium Channels; C492166:Kcnq4 protein, rat; D013440:Sulfides; D014662:Vasoconstrictor Agents; C025451:sodium bisulfide; D006862:Hydrogen Sulfide